Table 3.
Summary of the number of contacts showing significant phase-amplitude coupling (PAC) Change compared to ITI period
| Stimulus-locked segments | ||||
|---|---|---|---|---|
| ID | Number of contact shows active theta-LG PAC in incongruent condition |
Number of artifact-free trials/Number of total trials | ||
| Congruent | Incongruent | |||
| 1 | R | 0/2 | 62/64 | 60/64 |
| 2 | R | 1/3 | 62/64 | 59/64 |
| 3 | R | 1/2 | 61/64 | 57/64 |
| 4 | R | 0/3 | 60/64 | 61/64 |
| L | 0/4 | 60/64 | 61/64 | |
| 5 | R | 1/2 | 61/64 | 57/64 |
| 6 | R | 0/1 | 59/64 | 57/64 |
| L | 0/2 | 59/64 | 57/64 | |
| 7 | L | 2/2 | 24/32 | 23/32 (TRmin) |
| 8 | L | 2/4 | 55/64 | 47/64 |
| Response-locked segment | ||||
| ID | Number of contact shows active theta PAC |
Number of artifact-free trials/Number of total trials | ||
| Congruent | Incongruent | |||
| 1 | R | 0/2 | Same as the numbers in stimulus-locked information | |
| 2 | R | 1/3 | ||
| 3 | R | 0/3 | ||
| 4 | R | 0/3 | ||
| L | 0/4 | |||
| 5 | R | 0/2 | ||
| 6 | R | 0/1 | ||
| L | 0/2 | |||
| 7 | L | 0/2 | ||
| 8 | L | 0/4 | ||
Summary of contact in OFC for each patient. The total number of contacts and the number of contacts showing active theta-LG OAC changes are shown. Information on the number of trials that persisted for analysis after artifact removal is also displayed.